Available via license: CC BY 4.0
Content may be subject to copyright.
Antiinflammatory Activity of Cinnamon
(Cinnamomum zeylanicum) Bark Essential Oil in
a Human Skin Disease Model
Xuesheng Han*and Tory L. Parker
dōTERRA International, LLC, 389 S. 1300 W, Pleasant Grove, UT 84062, USA
The effect of cinnamon (Cinnamomum zeylanicum) bark essential oil (CBEO) on human skin cells has not been
elucidated. Therefore, we investigated the activity of a commercially available CBEO in a validated human
dermal fibroblast system, a model of chronic inflammation and fibrosis. We first evaluated the impact of CBEO
on 17 protein biomarkers that play critical roles in inflammation and tissue remodeling. The impact of CBEO on
genome-wide gene expression was also evaluated. CBEO showed strong anti-proliferative effects on skin cells
and significantly inhibited the production of several inflammatory biomarkers, including vascular cell adhesion
molecule-1, intercellular cell adhesion molecule-1, monocyte chemoattractant protein-1, interferon gamma-
induced protein 10, interferon-inducible T-cell alpha chemoattractant, and monokine induced by gamma
interferon. In addition, CBEO significantly inhibited the production of several tissue remodeling molecules,
including epidermal growth factor receptor, matrix metalloproteinase-1, and plasminogen activator inhibitor-1.
Macrophage colony-stimulating factor, which is an immunomodulatory protein molecule, was also significantly
inhibited by CBEO. Furthermore, CBEO significantly modulated global gene expression and altered signaling
pathways, many of which are important in inflammation, tissue remodeling, and cancer biology. The study shows
that CBEO is a promising antiinflammatory agent; however, further research is required to clarify its clinical
efficacy. © 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.
Keywords: cinnamon bark essential oil; cell proliferation; inflammation; VCAM-1; MIG; genome-wide gene expression.
INTRODUCTION
Cinnamon (Cinnamomum zeylanicum) bark essential
oil (CBEO) has been used for thousands of years in
Ayurvedic medicine to soothe aching joints and numb
pain. It is still used for similar purposes in India,
presumably because of its antiinflammatory property.
CBEO typically contains a very high amount of
cinnamaldehyde and a small amount of eugenol, among
many other aromatic compounds. CBEO and
cinnamaldehyde have been studied for their
antibacterial (Bardají et al., 2016), antifungal
(Ranasinghe et al., 2002), anti-diabetic (Anderson
et al., 2013; Sartorius et al., 2014), antiinflammatory
(Mendes et al., 2016; Chen et al., 2016), and anticancer
(Yang et al., 2015) activities, among others.
Furthermore, CBEO has gained popularity for use in
skin care products; however, research on its effects on
human skin is largely scarce. A recent study (Uchi
et al., 2017) conducted on human keratinocytes
demonstrated the antioxidant effect of cinnamaldehyde,
as well as its potential for treating skin disorders.
Therefore, we aimed to investigate the biological
activity of a commercially available CBEO in a human
dermal fibroblast system, which was designed to mimic
chronic inflammation and fibrosis. We first evaluated
the impact of CBEO on 17 protein molecules that are
relevant to the processes of inflammation, immune
response, and tissue remodeling. We also studied the
effects of CBEO on genome-wide gene expression.
The study provides important evidence of the biological
activity of CBEO in a human skin disease model.
MATERIALS AND METHODS
All experiments were conducted in a Biologically
Multiplexed Activity Profiling system HDF3CGF, a cell
culture of human dermal fibroblasts that is designed to
model chronic inflammation and fibrosis in a robust and
reproducible way. The system consists of three
components: a cell type, stimuli to create the disease
environment, and set of biomarker (protein) readouts to
examine how treatments affect that disease environment
(Berg et al., 2010). The methodologies used in this study
were essentially the same as those previously described
(Han and Parker, 2017a, 2017b; Han et al., 2017).
Reagents. Cinnamon bark essential oil (dōTERRA
International LLC, Pleasant Grove, UT, USA) was
diluted in DMSO to 8X the specified concentrations
[final DMSO concentration in culture media was no
more than 0.1% (v/v)]; 25 μL of each 8X solution was
added to the cell culture to a final volume of 200 μL.
DMSO [0.1% (v/v)] served as the vehicle control. Gas
* Correspondence to: Xuesheng Han, dōTERRA International, LLC, 389
S. 1300 W. Pleasant Grove, UT 84062, USA.
E-mail: lhan@doterra.com; lawry.han@gmail.com
Contract/grant sponsor: dōTERRA International.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
PHYTOTHERAPY RESEARCH
Phytother. Res. (2017)
Published online in Wiley Online Library
(wileyonlinelibrary.com) DOI: 10.1002/ptr.5822
© 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd.
Received 18 January 2017
Revised 31 March 2017
Accepted 03 April 2017
chromatography–mass spectrometry analysis of CBEO
indicated that its major chemical constitutes (i.e.,
>5%) were trans-cinnamaldehyde (59%) and cinnamyl
acetate (15%). The original gas chromatography–mass
spectrometry chromatogram is shown in Fig. S1, and a
list of all chemical constitutes found in CBEO is
provided in Table S1.
Cell cultures. Primary human neonatal fibroblasts were
obtained as previously described (Bergamini et al.,
2012) and were plated under low serum conditions
(0.125% fetal bovine serum) for 24 h. Then, the cell
culture was stimulated with a mixture of interleukin-
1β, tumor necrosis factor-α, interferon-γ, basic fibroblast
growth factor, epidermal growth factor, and platelet-
derived growth factor, for another 24 h. The cell culture
and stimulation conditions for the HDF3CGF assays
have been described in detail elsewhere and were
performed in a 96-well format (R Development Core
Team, 2011; Bergamini et al., 2012).
Protein-based readouts. An enzyme-linked
immunosorbent assay was used to measure the biomarker
levels of cell-associated and cell membrane targets.
Soluble factors from supernatants were quantified using
homogeneous time-resolved fluorescence detection,
bead-based multiplex immunoassay, or captured
enzyme-linked immunosorbent assay. Overt adverse
effects of the test agents on cell proliferation and viability
(cytotoxicity) were measured using SRB assay. For
proliferation assays, cells were cultured and then assayed
after 72 h, which was optimized for the HDF3CGF
system. Detailed information has been described
elsewhere (Bergamini et al., 2012). Measurements were
performed in triplicate wells, and a glossary of the
biomarkers used in this study is provided in Table S2.
Quantitative biomarker data are presented as the
mean log
10
relative expression level (compared with
the respective mean vehicle control value) ± standard
deviation of triplicate measurements. Differences in
biomarker levels between CBEO-treated and vehicle-
treated cultures were tested for significance with the
unpaired Student’st-test. A p-value <0.01, outside of
the significance envelope, with an effect size of at least
20% (more than 0.1 log
10
ratio units), was considered
statistically significant.
RNA isolation. Total RNA was isolated from cell lysates
using the Zymo Quick-RNA MiniPrep kit (Zymo
Research Corporation, Irvine, CA, USA), according to
manufacturer’s instructions. RNA concentration was
determined using NanoDrop ND-2000 (Thermo Fisher
Scientific, Waltham, MA, USA). RNA quality was
assessed with a Bioanalyzer 2100 (Agilent Technologies,
Santa Clara, CA, USA) and an Agilent RNA 6000 Nano
Kit. All samples had an A260/A280 ratio between 1.9 and
2.1, and an RNA integrity number score greater than 8.0.
Microarray analysis for genome-wide gene expression.
A 0.0012% (v/v) concentration of CBEO was tested
for its effect on expression of 21,224 genes in the
HDF3CGF system after 24 h treatment. Samples for
microarray analysis were processed by Asuragen, Inc.
(Austin, TX, USA), according to the company’s
standard operating procedures. Biotin-labeled cRNA
was prepared from 200 ng of total RNA with an Illumina
TotalPrep RNA Amplification kit (Thermo Fisher
Scientific) and one round of amplification. The cRNA
yields were quantified via UV spectroscopy, and the
distribution of transcript sizes was assessed using the
Agilent Bioanalyzer 2100. Labeled cRNA (750 ng) was
used to probe Illumina Human HT-12 v4 Expression
BeadChips (Illumina, Inc., San Diego, CA, USA).
Hybridizing, washing, staining with streptavidin-
conjugated Cyanine-3, and scanning of the Illumina
arrays was performed according to the manufacturer’s
instructions. Illumina BeadScan software was used to
produce the data files for each array; raw data were
extracted using Illumina BeadStudio software.
Raw data were uploaded into R (R Development
Core Team, 2011) and analyzed for quality-control
metrics using the beadarray package (Dunning et al.,
2007). Data were normalized using quantile
normalization (Bolstad et al., 2003), then re-annotated
and filtered to remove probes that were non-specific
or mapped to intronic or intragenic regions (Barbosa-
Morais et al., 2010). The remaining probe sets comprised
the data set for the remainder of the analysis. Fold-
change expression for each value was calculated as the
log
2
ratio of CBEO to vehicle control. These fold-
change values were uploaded to Ingenuity Pathway
Analysis (IPA, Qiagen, Redwood City, CA, www.
qiagen.com/ingenuity) to generate the network and
pathway analyses.
RESULTS AND DISCUSSION
Bioactivity profile of CBEO in pre-inflamed human
dermal fibroblasts
We analyzed CBEO’s biological activity in a dermal
fibroblast cell system, HDF3CGF, which mimics the
disease microenvironment of inflamed human skin cells
with already stimulated immune responses. Four different
concentrations (0.011, 0.0037, 0.0012, and 0.00041% v/v,
using DMSO as solvent) of CBEO were initially studied
for their effects on cell viability. The two high
concentrations were overtly cytotoxic; thus, only the
0.0012% v/vpreparation, which contained the highest
concentration of CBEO that was non-cytotoxic, was used
in further analyses. Key activities of biomarkers were
indicated when biomarker values for test samples were
significantly different (p<0.01) from the respective
values for the vehicle controls, with an effect size of at
least 20% (more than 0.1 log ratio units) (Fig. 1).
Cinnamon bark essential oil inhibited all the 17
biomarkers that were studied. It showed a significant
anti-proliferative activity against the dermal fibroblast
cells. CBEO also significantly inhibited the production
of inflammatory cytokines such as monocyte
chemoattractant protein-1, interferon gamma-induced
protein 10, interferon-inducible T-cell alpha
chemoattractant, and monokine induced by gamma
interferon (MIG). Furthermore, CBEO significantly
inhibited the production of vascular cell adhesion
X. HAN AND T.L. PARKER
© 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd. Phytother. Res. (2017)
molecule-1 (VCAM-1) and intercellular cell adhesion
molecule-1. The levels of several tissue remodeling
molecules, including epidermal growth factor receptor
(EGFR), matrix metalloproteinase 1, and plasminogen
activator inhibitor-1, were significantly decreased by
CBEO. CBEO also significantly reduced the levels of
macrophage colony-stimulating factor, which is an
immunomodulatory protein. The strong inhibitory effect
of CBEO on the increased production of these biomarkers
indicates that it may have an antiinflammatory property
and, therefore, promote wound healing.
Previous studies have indicated that CBEO and its
major active component cinnamaldehyde may have
promising antiinflammatory properties (Tung et al.,
2008; Wang et al., 2015). Chen et al. (2016)
demonstrated using an animal model that trans-
cinnamaldehyde suppresses lipopolysaccharide-induced
inflammation (Chen et al., 2016). Another study has
similarly reported on the antiinflammatory activity of
cinnamaldehyde (Mendes et al., 2016). The observed
strong antiinflammatory effect of CBEO in the human
skin disease model suggests that CBEO may be used
for treating inflammatory skin conditions.
In addition, the inhibitory effect of CBEO on the
production of tissue remodeling biomarkers in the
highly inflamed skin model suggests that CBEO and
cinnamaldehyde may be beneficial for wound healing.
This might be, at least, partially attributed to their
antiinflammatory and antimicrobial properties (Ghosh
et al., 2013; Wang et al., 2015).
Effects of CBEO on genome-wide gene expression
To further explore the biological activities of CBEO on
human skin cells, we studied the effect of the highest
concentration of CBEO that was not cytotoxic to the
cells (0.0012% v/v) on the RNA expression of 21,224
genes in the HDF3CGF system. The results showed a
significant, strong, and diverse effect of CBEO on the
regulation of the genes. Of the 200 genes that were
highly regulated by CBEO [log
2
(expression fold-
change ratio relative to vehicle control) ≥|1.5|], 148
genes were significantly downregulated, whereas 52
genes were significantly downregulated (Table S3). A
cross comparison of protein and gene expression data
showed that CBEO significantly inhibited the protein
and gene expression levels of MIG and VCAM-1.
The IPA showed that the bioactivity of CBEO
significantly overlapped with many canonical signaling
pathways from literature-validated databases (Fig. 2).
Some of these top signaling pathways (Table S4–S7),
such as the hepatic fibrosis activation pathway and the
antigen presentation pathway, are critically involved in
inflammation and tissue remodeling. Interestingly, many
pathways that play critical roles in cell cycle regulation,
cancer biology, and DNA damage response were also
on the list. The overall inhibitory effect of CBEO on
the genes studied and the signaling pathways is not only
consistent with its antiinflammatory and immune
modulating potential; however, it also suggests that
CBEO may play a role in modulating cell cycle
regulation and cancer signaling.
Cinnamon essential oil has been reported to show a
significant anticancer activity against head and neck
squamous cell carcinoma via the suppression of EGFR
tyrosine kinase (Yang et al., 2015). The EGFR tyrosine
kinase signaling pathway is important for the growth,
survival, proliferation, and differentiation of cells (Oda
et al., 2005). Cinnamaldehyde has also been reported to
be a potential anticancer drug (Hong et al., 2016),
primarily due to its anti-mutagenic, anti-tumorigenic,
anti-proliferative, and pro-apoptotic properties in cancer
cell lines. The findings of our study are largely consistent
with the anticancer properties of CBEO.
The current study has limitations. The in vitro study
results cannot be directly extrapolated to more complex
human skin systems. Moreover, the impact of CBEO on
human global gene expression was measured over a
short period. Therefore, how CBEO affects long-term
Figure 1. The bioactivity profile of cinnamon bark essential oil (0.0012% v/v) in the human dermal fibroblast system HDF3CGF. The x-axis
denotes protein-based biomarker readouts. The y-axis denotes the relative expression levels of biomarkers when compared with the values
for the vehicle control in log form. Vehicle control values are marked in gray at a 95% confidence level. * indicates a biomarker designated as
having ‘key activity’, which is when a biomarker value is significantly different (p<0.01) from the respective value for the vehicle control at a
studied concentration, with an effect size of at least 20% (more than 0.1 log ratio units). MCP-1, monocyte chemoattractant protein; VCAM-
1, vascular cell adhesion molecule 1; ICAM-1, intracellular cell adhesion molecule 1; IP-10, interferon gamma-induced protein 10; I-TAC,
interferon-inducible T-cell alpha chemoattractant; IL-8, interleukin-8; MIG, the monokine induced by gamma interferon; EGFR, epidermal
growth factor receptor; M-CSF, macrophage colony-stimulating factor; MMP-1, matrix metalloproteinase 1; PAI-1, plasminogen activator
inhibitor 1; TIMP, tissue inhibitor of metalloproteinase.
ANTIINFLAMMATORY ACTIVITY OF CINNAMON BARK ESSENTIAL OIL
© 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd. Phytother. Res. (2017)
gene expression remains elusive. Nevertheless, the data
from the current study provide important evidence of
the biological activities of CBEO in human skin cells
and suggest that CBEO is a promising antiinflammatory
agent.
CONCLUSIONS
To our knowledge, this is the first study to investigate
the biological activity of CBEO in a human skin disease
model. We found that CBEO significantly inhibited the
production of several protein biomarkers that are
involved in inflammation and tissue remodeling.
Moreover, CBEO showed significant anti-proliferative
activity against the skin cells used in the study.
Genome-wide gene expression analysis demonstrated
that CBEO significantly modulated global gene
expression and some signaling pathways. It was noted
that many of the genes and signaling pathways affected
by CBEO play critical roles in inflammation, immune
response, cancer biology, and DNA damage response.
The overall inhibitory effect of CBEO suggests its
potential in regulating the abovementioned biological
processes. However, further research is needed to
evaluate the mechanism of action of CBEO, as well as
its clinical efficacy and safety.
Acknowledgements
The study was funded by dōTERRA (Pleasant Grove, UT, USA) and
conducted at DiscoverX (Fremont, CA, USA).
Conflict of Interest
X.H. and T.P. are employees of dōTERRA, the manufacturer of the
CBEO used in the study.
REFERENCES
Anderson RA, Qin B, Canini F, Poulet L, Roussel AM. 2013.
Cinnamon counteracts the negative effects of a high fat/high
fructose diet on behavior, brain insulin signaling and
Alzheimer-associated changes. PLoS One 8: e83243.
Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, et al. 2010. A
re-annotation pipeline for Illumina BeadArrays: improving the
interpretation of gene expression data. Nucleic Acids Res 38:
e17.
Figure 2. Top 20 canonical pathways matching the bioactivity profile of cinnamon bark essential oil (0.0012% v/v) in gene expression in the
HDF3CGF system, as obtained from the IPA. The p-values were calculated using right-tailed Fisher’s exact test. Each p-value measures how
likely an observed association between a specific pathway and the dataset would be if it were only due to a random chance. The smaller the
p-value [bigger –ln (p-value), indicated by the black bars] for a pathway is, the more significantly it matches with the bioactivity of CBEO. A
ratio, indicated by the gray bar, was calculated by dividing the number of genes from the CBEO dataset that participated in a canonical
pathway by the total number of genes in that pathway. NRF2, nuclear factor E2-related factor 2; CHK, checkpoint kinase; PPAR, peroxisome
proliferator-activated receptor; Cdc 42, cell division control protein 42 homolog; BRCA1, breast cancer type 1 susceptibility protein; ERK5,
extracellular signal-regulated kinase 5.
X. HAN AND T.L. PARKER
© 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd. Phytother. Res. (2017)
Bardají DKR, Reis EB, Medeiros TCT, Lucarini R, Crotti AEM,
Martins CHG. 2016. Antibacterial activity of commercially
available plant-derived essential oils against oral pathogenic
bacteria. Nat Prod Res 30: 1178–1181.
Berg EL, Yang J, Melrose J, et al. 2010. Chemical target and
pathway toxicity mechanisms defined in primary human cell
systems. J Pharmacol Toxicol Methods 61:3–15.
Bergamini G, Bell K, Shimamura S, et al. 2012. A selective inhibitor
reveals PI3Kγdependence of T(H)17 cell differentiation. Nat
Chem Biol 8: 576–582.
Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A
comparison of normalization methods for high density
oligonucleotide array data based on variance and bias.
Bioinforma Oxf Engl 19: 185–193.
Chen YF, Wang YW, Huang WS, et al. 2016. Trans-cinnamaldehyde,
an essential oil in cinnamon powder, ameliorates cerebral
ischemia-induced brain injury via inhibition of neuroinflammation
through attenuation of iNOS, COX-2 expression and NFκ-B
signaling pathway. Neuromolecular Med 18: 322–333.
R Development Core Team. 2011. R: a language and environment
for statistical computing. Vienna, Austria: the R Foundation
for Statistical Computing.
Dunning MJ, Smith ML, Ritchie ME, Tavaré S. 2007. Beadarray: R
classes and methods for Illumina bead-based data. Bioinforma
Oxf Engl 23: 2183–2184.
Ghosh V, Saranya S, Mukherjee A, Chandrasekaran N. 2013.
Antibacterial microemulsion prevents sepsis and triggers
healing of wound in wistar rats. Colloids Surf B Biointerfaces
105: 152–157.
Han X, Parker TL. 2017a. Biological activity of vetiver (Vetiveria
zizanioides) essential oil in human dermal fibroblasts. Cogent
Med 4: 1298176.
Han X, Parker TL. 2017b. Arborvitae (Thuja plicata) essential oil
significantly inhibited critical inflammation- and tissue
remodeling-related proteins and genes in human dermal
fibroblasts. Biochim Open 4:56–60.
Han X, Rodriguez D, Parker TL. 2017. Biological activities of
frankincense essential oil in human dermal fibroblasts.
Biochim Open 4:31–35.
Hong SH, Ismail IA, Kang SM, Han DC, Kwon B-M. 2016.
Cinnamaldehydes in cancer chemotherapy. Phytother Res
30: 754–767.
Mendes SJF, Sousa FIAB, Pereira DMS, et al. 2016.
Cinnamaldehyde modulates LPS-induced systemic
inflammatory response syndrome through TRPA1-dependent
and independent mechanisms. Int Immunopharmacol 34:
60–70.
Oda K, Matsuoka Y, Funahashi A, Kitano H. 2005. A
comprehensive pathway map of epidermal growth factor
receptor signaling. Mol Syst Biol 1: 2005.0010.
Ranasinghe L, Jayawardena B, Abeywickrama K. 2002. Fungicidal
activity of essential oils of Cinnamomum zeylanicum (L.) and
Syzygium aromaticum (L.) Merr et L.M. Perry against crown
rot and anthracnose pathogens isolated from banana. Lett
Appl Microbiol 35: 208–211.
Sartorius T, Peter A, Schulz N, et al. 2014. Cinnamon extract
improves insulin sensitivity in the brain and lowers liver fat in
mouse models of obesity. PLoS One 9: e92358.
Tung Y-T, Chua M-T, Wang S-Y, Chang S-T. 2008. Anti-
inflammation activities of essential oil and its constituents
from indigenous cinnamon (Cinnamomum osmophloeum)
twigs. Bioresour Technol 99: 3908–3913.
Uchi H, Yasumatsu M, Morino-Koga S, Mitoma C, Furue M. 2017.
Inhibition of aryl hydrocarbon receptor signaling and induction
of NRF2-mediated antioxidant activity by cinnamaldehyde in
human keratinocytes. J Dermatol Sci 85:36–43.
Wang L, Hou Y, Yi D, et al. 2015. Beneficial roles of dietary oleum
cinnamomi in alleviating intestinal injury. Front Biosci
Landmark Ed 20: 814–828.
Yang XQ, Zheng H, Ye Q, Li RY, Chen Y. 2015. Essential oil
of cinnamon exerts anti-cancer activity against head and
neck squamous cell carcinoma via attenuating epidermal
growth factor receptor –tyrosine kinase. J BUON 20:
1518–1525.
SUPPORTING INFORMATION
Additional Supporting Information may be found
online in the supporting information tab for this article.
ANTIINFLAMMATORY ACTIVITY OF CINNAMON BARK ESSENTIAL OIL
© 2017 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd. Phytother. Res. (2017)